Patrick J. McEnany, President and CEO at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 125,430 shares at $6.17 ($768K) on 2021-08-13, disclosed to the SEC on 2021-08-17.
Open-market sale of $768k CPRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.07 | 31,529 | $191K | 24.9% |
| 2 | $6.07 | 31,529 | $191K | 24.9% |
| 3 | $6.17 | 31,186 | $192K | 25.1% |
| 4 | $6.17 | 31,186 | $192K | 25.1% |
| Total | $6.12 avg | 125,430 | $768K | 100% |
| Filing → |
| CPRX | SELL | 2024-11-15 | $4.1M | — | Filing → |
| CPRX | SELL | 2024-11-13 | $13.1M | — | Filing → |
| CPRX | SELL | 2023-05-17 | $692K | — | Filing → |